VANCOUVER, BC, March 13, 2025 /CNW/ - CareSpan Health, Inc. (the "Company") announces that it has changed its auditors from MNP LLP ("Former Auditor") to SRCO Professional Corporation ("Successor Auditor"). The Former Auditor resigned as the auditor of the Company on its own initiative effective March 5, 2025, and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective March 10, 2025, until the next Annual General Meeting of the Company.
There were no reservations in the Former Auditor's audit reports for the relevant period, being the financial year of the Company ended December 31, 2023, and any period subsequent to the most recently completed financial year for which an audit report was issued and preceding the resignation of the Former Auditor. In accordance with National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102"), the Company has filed a Change of Auditor Notice on March 13, 2025 with respect to the resignation of the Former Auditor and the appointment of the Successor Auditor (the "Notice") on SEDAR+ together with letters from both the Former Auditor and Successor Auditor, with each letter confirming agreement with the statements contained in the respective Notices, as applicable. There were no reportable events as defined in NI 51-102 between the Former Auditor and the Company.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Last Trade: | C$0.02 |
Daily Volume: | 0 |
Market Cap: | C$952K |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load